Works matching IS 14642662 AND DT 2005 AND VI 6 AND IP 4
Results: 11
Influence of RANTES, SDF-1 and TGF-ß levels on the value of interleukin-7 as a predictor of virological response in HIV-1-infected patients receiving double boosted protease inhibitor-based therapy.
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
In the era of highly active antiretroviral therapy, why are HIV-infected patients still admitted to hospital for an inaugural opportunistic infection?
- Published in:
- HIV Medicine, 2005, v. 6, n. 4, p. 232, doi. 10.1111/j.1468-1293.2005.00282.x
- By:
- Publication type:
- Article
Clinical characteristics and mid-term prognosis of acute coronary syndrome in HIV-infected patients on antiretroviral therapy.
- Published in:
- HIV Medicine, 2005, v. 6, n. 4, p. 240, doi. 10.1111/j.1468-1293.2005.00283.x
- By:
- Publication type:
- Article
Body shape and composition in HIV-infected women: an urban cohort.
- Published in:
- HIV Medicine, 2005, v. 6, n. 4, p. 245, doi. 10.1111/j.1468-1293.2005.00284.x
- By:
- Publication type:
- Article
Prevention of cryptococcosis in HIV-infected patients with limited access to highly active antiretroviral therapy: evidence for primary azole prophylaxis.
- Published in:
- HIV Medicine, 2005, v. 6, n. 4, p. 253, doi. 10.1111/j.1468-1293.2005.00289.x
- By:
- Publication type:
- Article
Lipoatrophic men 44 months after the diagnosis of lipoatrophy are less lipoatrophic but more hypertensive.
- Published in:
- HIV Medicine, 2005, v. 6, n. 4, p. 260, doi. 10.1111/j.1468-1293.2005.00305.x
- By:
- Publication type:
- Article
Influence of RANTES, SDF-1 and TGF-β levels on the value of interleukin-7 as a predictor of virological response in HIV-1-infected patients receiving double boosted protease inhibitor-based therapy.
- Published in:
- HIV Medicine, 2005, v. 6, n. 4, p. 268, doi. 10.1111/j.1468-1293.2005.00306.x
- By:
- Publication type:
- Article
Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
- Published in:
- HIV Medicine, 2005, v. 6, n. 4, p. 278, doi. 10.1111/j.1468-1293.2005.00307.x
- By:
- Publication type:
- Article
Incidence of and risk factors for tenofovir-induced nephrotoxicity: a retrospective cohort study.
- Published in:
- HIV Medicine, 2005, v. 6, n. 4, p. 284, doi. 10.1111/j.1468-1293.2005.00308.x
- By:
- Publication type:
- Article
The role of diet, exercise and smoking in dyslipidaemia in HIV-infected patients with lipodystrophy.
- Published in:
- HIV Medicine, 2005, v. 6, n. 4, p. 291, doi. 10.1111/j.1468-1293.2005.00309.x
- By:
- Publication type:
- Article
New drugs.
- Published in:
- HIV Medicine, 2005, v. 6, n. 4, p. 225, doi. 10.1111/j.1468-1293.2005.00310.x
- By:
- Publication type:
- Article